CD27 anticorps (APC)
-
- Antigène Voir toutes CD27 Anticorps
- CD27 (CD27 Molecule (CD27))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CD27 est conjugé à/à la APC
-
Application
- Flow Cytometry (FACS)
- Specificité
- Reacts with CD27 (T14), a 50-55 kD type I transmembrane glycoprotein (member of the TNF-receptor superfamily) expressed on medullary thymocytes, peripheral T lymphocytes, some B lymphocytes and NK cells.
- Purification
- Ion exchange chromatography
- Immunogène
-
Human peripheral blood lymphocytes.
Type of Immunogen: Cells - Clone
- LT27
- Isotype
- IgG2a
- Top Product
- Discover our top product CD27 Anticorps primaire
-
-
- Indications d'application
-
Approved: Flo
Usage: The reagent is designed for Flow Cytometry analysis of human blood cells using 10 μL reagent / 100 μL of whole blood or 106 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, 15 mM sodium azide, 0.2 % high-grade protease free BSA as a stabilizing agent.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
- Antigène
- CD27 (CD27 Molecule (CD27))
- Autre désignation
- CD27 (CD27 Produits)
- Synonymes
- anticorps TNFRSF7, anticorps S152, anticorps Tnfrsf7, anticorps Tp55, anticorps S152. LPFS2, anticorps T14, anticorps CD27 molecule, anticorps CD27 antigen, anticorps CD27, anticorps Cd27
- Sujet
-
Name/Gene ID: CD27
Family: TNF Receptor
Synonyms: CD27, CD27 antigen, CD27 Molecule, S152, T14, T-cell activation antigen CD27, CD27L receptor, T cell activation antigen S152, TNFRSF7, Tp55 - ID gène
- 939
- UniProt
- P26842
- Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-